CRH Medical Corporation Common Shares of Beneficial Interest (CRHM): Price and Financial Metrics
CRH Medical Corporation Common Shares of Beneficial Interest (CRHM)
Today's Latest Price: $2.20 USD
Updated Oct 23 8:00pm
Add CRHM to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 70 in Medical - Services
See all "A" rated Strong Buy stocks
CRHM Stock Summary
- CRHM's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.2 -- higher than merely 4.26% of US-listed equities with positive expected earnings growth.
- Of note is the ratio of CRH Medical Corp's sales and general administrative expense to its total operating expenses; 87.82% of US stocks have a lower such ratio.
- For CRHM, its debt to operating expenses ratio is greater than that reported by 88.9% of US equities we're observing.
- Stocks with similar financial metrics, market capitalization, and price volatility to CRH Medical Corp are AQMS, CHCI, FN, OGI, and DHIL.
- CRHM's SEC filings can be seen here. And to visit CRH Medical Corp's official web site, go to investors.crhsystem.com.
CRHM Stock Price Chart Interactive Chart >
CRHM Price/Volume Stats
| Current price | $2.20 | 52-week high | $4.43 |
| Prev. close | $2.21 | 52-week low | $0.86 |
| Day low | $2.18 | Volume | 46,156 |
| Day high | $2.22 | Avg. volume | 107,930 |
| 50-day MA | $2.30 | Dividend yield | N/A |
| 200-day MA | $2.47 | Market Cap | 157.30M |
CRH Medical Corporation Common Shares of Beneficial Interest (CRHM) Company Bio
CRH Medical Corporation, a medical company, provides products and services to physicians for the treatment of gastrointestinal diseases in the United States. The company was founded in 2000 and is based in Vancouver, Canada.
CRHM Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $2.20 | $7.9 | 254% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for CRH Medical Corp. To summarize, we found that CRH Medical Corp ranked in the 72th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. The most interesting components of our discounted cash flow analysis for CRH Medical Corp ended up being:
- CRH Medical Corp's weighted average cost of capital (WACC) is 10%; for context, that number is higher than 72.61% of tickers in our DCF set.
- CRHM's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 13%; for context, that number is higher than 72.61% of tickers in our DCF set.
- Relative to other stocks in its sector (Healthcare), CRH Medical Corp has a reliance on debt greater than 68.63% of them.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 247% |
| 1% | 251% |
| 2% | 254% |
| 3% | 258% |
| 4% | 261% |
| 5% | 265% |
HUM, UHS, NVO, SKVI, and DVA can be thought of as valuation peers to CRHM, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...